Search

Mr Praveen Patel

Ophthalmology

 

  • Fee assured
Overview
COVID-19

This healthcare professional is currently treating patients. Please speak to them to find out more about their availability.

Last updated: 12 Nov 2020

About me

Mr Patel is an internationally renowned expert in the treatment of diseases that affect the macula. He qualified as a doctor at Cambridge University where he obtained a first class degree. He completed his postgraduate training in Ophthalmology at the world-famous Moorfields Eye Hospital, London. He was a clinical research Fellow at Moorfields and at the UCL Institute of Ophthalmology. As one of the lead investigators for the world’s first randomised trial of Avastin for age-related macular degeneration he won the Moorfields Research Medal for his work now published in the British Medical Journal. He has also carried out research validating new imaging modalities for the assessment of macular disease.

He has earned a reputation among patients and colleagues for providing excellence in the care of the patient with macular disease including the use of Lucentis, Avastin, Eylea and Ozurdex injections, verteporfin photodynamic therapy and advanced macular laser treatments. He is also actively involved in research to find novel therapies for macular disease including age-related macular degeneration and offers access to latest treatments including Eylea injections for macular disease.

Areas of interest

Age-related macular degeneration; Diabetic retinopathy; Retinal vein occlusion; Macular oedema; Central serous chorioretinopathy (CSR); vitreomacular traction (VMT); General ophthalmology; Blepharitis; Conjunctivitis; Red eye; Dry eye; Floaters; Flashing lights; Blurred vision; Retinal disease with cataract; Watery eyes

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • C7923

    Intravitreal injection of pharmaceutical for neovascular age related macular degeneration - (5-50)

    Ramsay Rivers Hospital (5-50)

  • C6920

    Paracentesis - (1-5)

    London Medical (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.